[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-14409":3,"doc-seo-14409":27},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"file_id":15,"file_url":16,"file_type":17,"file_size":18,"view_count":19,"is_deleted":4,"is_public":20,"is_downloadable":20,"audit_status":20,"page_count":21,"language":22,"language_code":23,"table_of_contents":24,"faqs":24,"seo_title":13,"seo_description":14,"update_tm":25,"read_time":26},14409,137441390410,"Hazel","https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984",7,"Healthcare","GLP-1 Receptor Agonists","Review of the discovery and development of incretin biology leading to glucagon-like peptide-1 (GLP-1) receptor agonists. Traces the identification of GLP-1 and exendin-4, early clinical advances such as exenatide, and the role of glucose-dependent insulinotropic peptide (GIP). Summarizes mechanisms including insulin secretion, glucagon inhibition, effects on gastric emptying, metabolic and cellular prosurvival pathways, and potential links to gut microbiota and combination therapies for type 2 diabetes and obesity.","cbCairrxN59KgfYS","https://ap.wps.com/l/cbCairrxN59KgfYS","pdf",1214156,10,1,12,"English","en","",1776558977,30,{"code":4,"msg":28,"data":29},"ok",{"site_id":30,"language":23,"slug":31,"title":13,"keywords":24,"description":14,"schema_data":32,"social_meta":67,"head_meta":70,"extra_data":72,"updated_unix":25},105,"glp-1-receptor-agonists",{"@graph":33,"@context":66},[34,51],{"@type":35,"itemListElement":36},"BreadcrumbList",[37,41,45,48],{"item":38,"name":39,"@type":40,"position":20},"https://docshare.wps.com","Home","ListItem",{"item":42,"name":43,"@type":40,"position":44},"https://docshare.wps.com/document/","Document",2,{"item":46,"name":12,"@type":40,"position":47},"https://docshare.wps.com/document/healthcare/",3,{"item":49,"name":13,"@type":40,"position":50},"https://docshare.wps.com/document/glp-1-receptor-agonists/14409/",4,{"url":49,"name":13,"@type":52,"author":53,"headline":13,"publisher":55,"fileFormat":58,"description":14,"dateModified":59,"datePublished":60,"encodingFormat":58,"isAccessibleForFree":61,"interactionStatistic":62},"DigitalDocument",{"name":9,"@type":54},"Person",{"url":38,"name":56,"@type":57},"DocShare","Organization","application/pdf","2026-06-05","2026-04-19",true,{"@type":63,"interactionType":64,"userInteractionCount":19},"InteractionCounter",{"@type":65},"ViewAction","https://schema.org",{"og:url":68,"og:type":69,"og:title":13,"og:site_name":56,"og:description":14},"https://docshare.wps.com/document/glp-1-receptor-agonists/14409","article",{"robots":71,"canonical":68},"index,follow",{"doc_id":7,"site_id":30}]